BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17082327)

  • 1. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.
    Yang Z; Chang YJ; Miyamoto H; Ni J; Niu Y; Chen Z; Chen YL; Yao JL; di Sant'Agnese PA; Chang C
    Mol Endocrinol; 2007 Feb; 21(2):343-58. PubMed ID: 17082327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.
    Yang Z; Chang YJ; Miyamoto H; Yeh S; Yao JL; di Sant'Agnese PA; Tsai MY; Chang C
    Endocrinology; 2007 Mar; 148(3):1340-9. PubMed ID: 17110431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53.
    Zhang ZW; Yang ZM; Zheng YC; Chen ZD
    Asian J Androl; 2010 Mar; 12(2):186-95. PubMed ID: 20098441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.
    Ting HJ; Bao BY; Hsu CL; Lee YF
    Endocrine; 2005 Feb; 26(1):1-9. PubMed ID: 15805579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor.
    Kang HY; Yeh S; Fujimoto N; Chang C
    J Biol Chem; 1999 Mar; 274(13):8570-6. PubMed ID: 10085091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
    Chang HC; Chen SC; Chen J; Hsieh JT
    J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
    Mu X; Chang C
    Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
    Mashima T; Okabe S; Seimiya H
    Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
    Kikuchi H; Uchida C; Hattori T; Isobe T; Hiramatsu Y; Kitagawa K; Oda T; Konno H; Kitagawa M
    Carcinogenesis; 2007 Aug; 28(8):1752-8. PubMed ID: 17510080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K; Kawada M; Ohba S; Takamoto K; Ishizuka M
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):175-87. PubMed ID: 15062556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.